Navigation Links
AVI BioPharma Reports Positive Pre-Clinical Influenza Data

e. These include three subtypes that caused pandemics in the 20th century -- the 1918 Spanish flu (H1N1), the 1957 Asian flu (H2N2) and the 1968 Hong Kong flu (H3N2) -- and three subtypes of avian flu that have been reported to cause disease in humans (H5N1, H7N7 and H9N2). AVI's potential treatment for seasonal influenza A will be made available to potential licensees.

About Influenza A Viruses

Influenza, or flu, is a contagious respiratory illness caused by influenza viruses. On average 5 percent to 20 percent of the U.S. population is infected with the flu each year. Influenza A virus is an enveloped negative-strand RNA virus, with eight genome segments that code for 10 proteins. Influenza strains are subtyped according to the antigenic and genetic nature of their surface glycoproteins: hemagglutinin (HA or H) and neuraminidase (NA or N). Fifteen H and nine N subtypes have been identified, with three associated with widespread human disease (H1N1, H2N2 and H3N2). In addition, several subtypes of avian influenza virus -- H5N1, H7N7 and H9N2 -- can infect and cause disease in humans.

The current influenza pandemic in birds throughout Asia, Eastern Europe and Turkey is caused by the H5N1 subtype. It is thought that co-infection of humans or certain animals (such as pigs) with both H1N1 and H5N1 can lead to a reassortment or recombination of viral particles, resulting in the emergence of a virus with dangerous public health properties, namely one to which the human population has no natural immunity and which has the ability to spread easily from person to person. It is believed that emergence of avian flu by this general mechanism may have led to the worldwide pandemics of 1918, 1957 and 1968.

About AVI BioPharma

AVI BioPharma develops therapeutic products for the treatment of life-threatening diseases using third-generation NEUGENE antisense drugs and ESPRIT exon skipping technology. AVI's lead NEUGENE antisense compound is design
'"/>




Page: 1 2 3

Related medicine technology :

1. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
2. Array BioPharma to Present at the C.E Unterbeg, Towbin Emerging Growth Conference
3. DOR BioPharma Announces Issuance of European Patent for Its Oral Multivalent Botulinum Toxin Vaccine BT-VACC
4. DOR BioPharma Announces Publication Describing Results of Its Multivalent Botulinum Toxin Vaccine BT-VACC
5. Array BioPharma Reports New Clinical Data on Its Anti-Inflammatory Drugs
6. PDL BioPharma Announces Long-Term Nuvion Data Presented at 2007 Digestive Disease Week
7. Helix BioPharma Corp. Announces Positive Phase II Clinical Results with its Topical Interferon Alpha-2b
8. CeNeRx BioPharma Announces Positive Phase I Results in First Human Trial of Third Generation RIMA Antidepressant
9. Integrated BioPharmas Proprietary Vaccine Technology Achieves Strong Positive Results
10. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
11. Cobalis Reports Phase III Trial Results for PreHistin in Seasonal Allergic Rhinitis
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: AVI BioPharma Reports Positive Pre Clinical Influenza Data
(Date:8/4/2015)... Calif., Aug. 4, 2015  Xencor, Inc. (NASDAQ: ... engineered monoclonal antibodies for the treatment of autoimmune ... reported financial results for the second quarter ended June ... business highlights. "Currently eight XmAb® antibody ... and two internal. The accelerating momentum of this ...
(Date:8/4/2015)... DUBLIN , Aug. 04, 2015 ... ) has announced the addition of the ... Patient Comfort and Operational Efficiency, with Growth Driven ... "MRI Systems Market to 2020 - ... Growth Driven by Developing Economies" discusses the market, ...
(Date:8/4/2015)... -- Levi & Korsinsky is investigating the Board of ... BIIB) for possible violations of federal securities laws. The ... and/or directors have violated Sections 10(b) and 20(a) of ... 24, 2015, prior to the opening of the market, ... other things, the Company lowered its prior revenue guidance ...
Breaking Medicine Technology:Xencor Reports Second Quarter 2015 Financial and Operating Results 2Xencor Reports Second Quarter 2015 Financial and Operating Results 3Xencor Reports Second Quarter 2015 Financial and Operating Results 4Xencor Reports Second Quarter 2015 Financial and Operating Results 5Xencor Reports Second Quarter 2015 Financial and Operating Results 6Xencor Reports Second Quarter 2015 Financial and Operating Results 7Xencor Reports Second Quarter 2015 Financial and Operating Results 8Xencor Reports Second Quarter 2015 Financial and Operating Results 9Global MRI Systems Market Outlook to 2020 - Focus on Patient Comfort and Operational Efficiency, with Growth Driven by Developing Economies 2SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation of Biogen Inc. and Its Board of Directors in Connection with Possible Violations of Federal Securities Laws -- BIIB 2
... March 11, 2011 On March 11, 2011, the ... issued a decision as to a portion of the ... CEPH ), ("Cephalon") and its wholly-owned subsidiary CIMA Labs, ... subsidiary Watson Laboratories, Inc., (collectively "Watson") pertaining to Cephalon,s ...
... Wash., March 11, 2011 SCOLR Pharma, Inc. (OTC ... has received a letter from the Food and Drug ... Application (ANDA) for extended-release pseudoephedrine.   The ... that the FDA had with the conduct of the ...
Cached Medicine Technology:Court Rules on First Set of Patents in FENTORA Litigation 2SCOLR Pharma, Inc. Receives Deficiency Letter from FDA on Pseudoephedrine Application 2
(Date:8/4/2015)... ... ... The Journal of Pain Research has published the review “ ... Okifuji says “Both obesity and chronic pain are serious public health concerns in our ... the other. Rather, there appear to be multiple factors that contribute to each of ...
(Date:8/4/2015)... ... August 04, 2015 , ... Atlantic Health System, one of the largest health ... among the top five in their list of the 20 Best Workplaces in Health ... Chilton Medical Centers, Goryeb Children’s Hospital and Atlantic Rehabilitation, is the highest-ranking company from ...
(Date:8/4/2015)... CA (PRWEB) , ... August 04, 2015 , ... An ... that found financial incentives to be a viable method for encouraging people to lose ... money on the future of their weight loss success, adding a financial incentive to ...
(Date:8/4/2015)... ... August 04, 2015 , ... PerceptiMed, ... Richard Carmona, M.D., M.P.H., FACS, to its Board of Directors effective August 1, ... lives," Dr. Carmona said. "I strongly believe in the mission of the company ...
(Date:8/4/2015)... ... ... One of the nation’s leading experts in chronic pain management has scheduled ... , which provides strategies for people who suffer from chronic pain. Dr. Mel ... the book in conjunction with Katherine Ketcham, an author who specializes in writing about ...
Breaking Medicine News(10 mins):Health News:The Association between Chronic Pain and Obesity published by Dove Medical Press 2Health News:Atlantic Health System Named a 'Best Workplace in Health Care' by Fortune, Great Place to Work® 2Health News:Atlantic Health System Named a 'Best Workplace in Health Care' by Fortune, Great Place to Work® 3Health News:Atlantic Health System Named a 'Best Workplace in Health Care' by Fortune, Great Place to Work® 4Health News:Article on Incentivizing Weight Loss Mirrors Similar Motivations Surrounding Weight Loss Surgery, Says Dr. Feiz & Associates 2Health News:Dr. Richard Carmona, 17th Surgeon General of the United States, Joins PerceptiMed, Inc.’s Board of Directors 2Health News:Dr. Richard Carmona, 17th Surgeon General of the United States, Joins PerceptiMed, Inc.’s Board of Directors 3Health News:Medical Expert's New Book Offers Help for Chronic Pain Sufferers 2Health News:Medical Expert's New Book Offers Help for Chronic Pain Sufferers 3
... Being Proactive, Reducing Risks for Dementia NEW YORK, May 6 ... for a brisk walk, eaten dark leafy vegetables or toured a ... types of lifestyle choices that can pay off now and in ... new interactive Web site - www.alzprevention.org ...
... blood lactate level. It indicates how much lactic acid ... physical exertion and enables conclusions to be drawn about ... performance diagnosis sessions. As they pedal a cycle ergometer ... samples from an earlobe. A special device then measures ...
... TAMPA, Fla., May 6 - ... to be diagnosed with breast or gynecologic cancers ... leading the current movement toward focusing more on ... ground within the field of women,s oncology.(Photo: ...
... speak on ,Upstream Processing of Medications, at this year,s ... and Marina . ENGLEWOOD, Colo., May ... Corporation, is sponsoring a professional presentation discussing the accuracy ... this year,s unSUMMIT for Bedside Barcoding, May 6-8, in ...
... American Cancer Society in providing services to newly ... WellPoint Foundation, LLC, a private, non-profit organization wholly ... in the total amount of $1 million to ... of its Hope Lodge network and Patient Navigation ...
... Up in ICU and Writes Notes to Fiancée , ... Tucson, Ariz. ... Medical Center (UMC) after making medical history. He is only the third ... kidney transplant on the same day after living with the SynCardia ...
Cached Medicine News:Health News:Alzheimer's Foundation of America Lays Out Strategies for Healthy Aging 2Health News:Alzheimer's Foundation of America Lays Out Strategies for Healthy Aging 3Health News:Lactate test made easy 2Health News:Video: Research in Women's Cancers Leading the Personalized Medicine Revolution 2Health News:Chief Technology Officer for Baxa Corporation's Subsidiary, FHT, Inc., Presents at the Fourth Annual unSUMMIT for Bedside Barcoding in Tampa, Florida 2Health News:Chief Technology Officer for Baxa Corporation's Subsidiary, FHT, Inc., Presents at the Fourth Annual unSUMMIT for Bedside Barcoding in Tampa, Florida 3Health News:American Cancer Society Awarded Dual WellPoint Foundation Grants to Expand Hope Lodge Network and Patient Navigation Program 2Health News:American Cancer Society Awarded Dual WellPoint Foundation Grants to Expand Hope Lodge Network and Patient Navigation Program 3Health News:American Cancer Society Awarded Dual WellPoint Foundation Grants to Expand Hope Lodge Network and Patient Navigation Program 4Health News:Total Artificial Heart Patient 3rd in the World to Receive Dual Transplants 2
The American Heritage® Stedman's Medical Dictionary is a work for consumers and patients concerned with medicine and health today....
Stedmans Medical Dictionary is a PDA reference for nursing and allied health professionals and students....
With Skyscape's smARTlink technology, Tabers can cross-index with other clinical and drug prescription products from Skyscape to provide an integrated source of clinical information....
A charge capture solution for physicians. Use your handheld to track hospital and ambulatory charges....
Medicine Products: